Europe falls behind U.S. in funding coronavirus vaccine and securing access

Wall Street Journal

19 May 2020 - U.S. was faster in shouldering drug companies’ costs to develop and manufacture vaccine candidates, putting the bloc at a disadvantage.

As pharmaceutical giants edge closer to a potential vaccine for the new coronavirus, governments demanding access to any supplies are running up against a hard reality: the bill.

The tension was cast into relief last Thursday when Sanofi chairman Serge Weinberg took a call from French Prime Minister Édouard Philippe, according to a person familiar with the matter.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder